Your browser doesn't support javascript.
loading
Suggested new breakpoints of anti-MERS-CoV antibody ELISA titers: performance analysis of serologic tests.
Ko, J-H; Müller, M A; Seok, H; Park, G E; Lee, J Y; Cho, S Y; Ha, Y E; Baek, J Y; Kim, S H; Kang, J-M; Kim, Y-J; Jo, I J; Chung, C R; Hahn, M-J; Drosten, C; Kang, C-I; Chung, D R; Song, J-H; Kang, E-S; Peck, K R.
Afiliação
  • Ko JH; Division of Infectious Diseases, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 135-710, Republic of Korea.
  • Müller MA; Division of Infectious Diseases, Department of Internal Medicine, Armed Forces Capital Hospital, Seongnam, South Korea.
  • Seok H; Institute of Virology, Charité - Universitätsmedizin Berlin, Helmut-Ruska-Haus Charitéplatz 1, 10117, Berlin, Germany.
  • Park GE; German Centre for Infection Research, Braunschweig, Germany.
  • Lee JY; Division of Infectious Diseases, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 135-710, Republic of Korea.
  • Cho SY; Division of Infectious Diseases, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 135-710, Republic of Korea.
  • Ha YE; Division of Infectious Diseases, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 135-710, Republic of Korea.
  • Baek JY; Division of Infectious Diseases, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 135-710, Republic of Korea.
  • Kim SH; Division of Infectious Diseases, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 135-710, Republic of Korea.
  • Kang JM; Asia Pacific Foundation for Infectious Diseases (APFID), Seoul, Republic of Korea.
  • Kim YJ; Asia Pacific Foundation for Infectious Diseases (APFID), Seoul, Republic of Korea.
  • Jo IJ; Division of Infectious Diseases, Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Chung CR; Division of Infectious Diseases, Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Hahn MJ; Department of Emergency Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Drosten C; Department of Critical Care Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Kang CI; Department of Molecular Cell Biology, Center for Molecular Medicine, Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine, Suwon, 440-746, South Korea.
  • Chung DR; Institute of Virology, Charité - Universitätsmedizin Berlin, Helmut-Ruska-Haus Charitéplatz 1, 10117, Berlin, Germany.
  • Song JH; German Centre for Infection Research, Braunschweig, Germany.
  • Kang ES; Division of Infectious Diseases, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 135-710, Republic of Korea.
  • Peck KR; Division of Infectious Diseases, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 135-710, Republic of Korea.
Eur J Clin Microbiol Infect Dis ; 36(11): 2179-2186, 2017 Nov.
Article em En | MEDLINE | ID: mdl-28695355

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ensaio de Imunoadsorção Enzimática / Testes Sorológicos / Infecções por Coronavirus / Coronavírus da Síndrome Respiratória do Oriente Médio / Anticorpos Antivirais Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ensaio de Imunoadsorção Enzimática / Testes Sorológicos / Infecções por Coronavirus / Coronavírus da Síndrome Respiratória do Oriente Médio / Anticorpos Antivirais Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article